PITTSBURGH — A new machine learning model uses electrocardiogram (ECG) readings to diagnose and classify heart attacks faster and more accurately than current approaches, according to a study led by University of Pittsburgh researchers that published today in Nature Medicine. “When a patient comes into the hospital with chest pain, the first […]
Other News
PocDoc partners with NHS Targeted Lung Health Programme in North East, leveraging new biomarker Coronary Artery Calcium, to identify patients at increased risk of cardiovascular disease
CAMBRIDGE, England, June 29, 2023 /PRNewswire/ — PocDoc, the Cambridge-based digital health platform, today announces a major pilot with the NHS Targeted Lung Health Check programme in the North East, in partnership with cardiologist Dr Alan Bagnall and the NIHR Clinical Research Network North East and North Cumbria (CRN NENC). As documented widely in recent weeks, the NHS England Targeted […]
Core Sound Imaging’s Studycast Integration Program impacts hospital workflows
[Health System in New York City pilots the Studycast Integration Program using Us2.ai’s complete echo AI tools for automating echo measurements. Core Sound Imaging’s Studycast Integration Program has been designed to deliver a frictionless workflow for AI tools.] RALEIGH, N.C., June 28, 2023 /PRNewswire/ — Core Sound Imaging, Inc., creators of the Studycast® system, and Us2.ai […]
Translumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices, Netherlands
The acquisition gives access to a patented, innovative, and proven next-generation Drug Coated Balloon (DCB) technology that may revolutionize the scope of complex coronary interventions NEW DELHI and HELMOND, Netherlands, June 29, 2023 /PRNewswire/ — Translumina, a global leader in Interventional Cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Blue […]
Berlin Heals Holding AG Successfully Completes Financing Round for Ongoing CE-Study
ZUG, Switzerland, June 29, 2023 /PRNewswire/ — Berlin Heals Holding AG, a MedTech startup, has developed a breakthrough method and a product for the therapy of heart failure. The product – an electronic device called C-MIC – has already successfully been tested in patients in a pilot study and is currently undergoing CE […]
Rivus Pharmaceuticals Announces Leadership Transition, Appointment of Jayson Dallas, M.D., as CEO
– Allen Cunningham appointed Chief Operating Officer, guiding execution of the company’s clinical programs for HU6 to treat cardiometabolic disease CHARLOTTESVILLE, Va. and SAN FRANCISCO, June 29, 2023 /PRNewswire/ — Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardiometabolic health, today announced the appointment of Jayson Dallas, M.D., executive chairman for Rivus Pharmaceuticals, as Chief Executive […]
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
HINGHAM, Mass., June 29, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, today announced the successful completion of an extended pre-clinical study held by leading key opinion leaders (“KOLs”) at a New York-based research lab. […]
CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded Warrants
BERKELEY HEIGHTS, N.J., June 28, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced the pricing of its previously announced underwritten public offering of 7,500,000 shares of its common […]
BioSig Joins Webull Corporate Connect
Webull’s investor community can now access real-time BioSig investor communications and Q&A Westport, CT, June 29, 2023 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that it is now actively participating on the […]
NeuroPace Announces CEO Transition
NeuroPace Appoints Joel Becker as President & CEO Becker Brings a Track Record of Strong Commercial Execution and Deep Medical Device Operating Expertise Mike Favet to leave Company after four years as President, CEO and Board Member and will continue to advise through transition MOUNTAIN VIEW, Calif., June 28, 2023 […]



